RecruitingOBSERVATIONAL

Biology of Juvenile Myoclonic Epilepsy

This important study, called 'Biology of Juvenile Myoclonic Epilepsy,' is looking into the genetic roots of a common form of epilepsy called JME. Researchers are gathering blood samples and health details, including brainwave test results, from over 1000 people with JME across the UK, Europe, and North America. They're comparing this information with similar data from 2000 people who don't have epilepsy. The main goal is to discover the specific genetic changes that cause JME. Understanding these causes is a crucial step towards developing more effective treatments and potentially even finding JME earlier in people's lives.

At a glance

Status

Recruiting

Sponsor

King's College London

Enrolment target

1,000

Start

13 Jul 2017

Estimated completion

31 Dec 2026

Juvenile Myoclonic Epilepsy

What is this study about?

Epilepsy is a common condition affecting the brain, and it can start in childhood for many. There are lots of different types, and a common one, especially in younger people, is called 'Juvenile Myoclonic Epilepsy' or JME. We know that JME often runs in families, and there's strong evidence that changes in our genes, which are like our body's instruction manual, play a big part in why it happens.

This study is all about finding those specific genetic changes. Researchers will look at the genetic information from people with JME and compare it to people who don't have epilepsy. They'll also consider information from brainwave tests (EEGs) which are used to help diagnose epilepsy. By doing this comparison on a large scale, they hope to get a much clearer picture of what exactly in our genes leads to JME.

Finding the genetic causes of JME is a really important step. It could help us understand the condition much better, leading to new and perhaps more personalised treatments. We might even be able to detect JME earlier, allowing for better care and support. While you won't personally benefit directly from taking part, your contribution could make a real difference for others with JME in the future.

Key takeaways

Aims to find genetic causes of Juvenile Myoclonic Epilepsy (JME).
Involves a single blood sample and sharing existing medical information.
No direct benefit for individuals taking part, but helps future patients.
Comparing genetic information from people with JME to those without epilepsy.
Could lead to better understanding, diagnosis, and treatments for JME.
You cannot refer yourself; typically, your doctor would discuss participation.

Who may be eligible?

To be considered for this study, you would generally need to have a diagnosis of Juvenile Myoclonic Epilepsy (JME). Your myoclonic jerks (sudden, brief muscle twitches) should have started between the ages of 10 and 25 years, and mostly involve your arms, especially in the mornings. Brainwave tests (EEGs) should show typical patterns for JME. You'll also need to be currently between 10 and 40 years old.

There are also some reasons why you might not be able to join. For example, if your myoclonic jerks are only due to certain medications like carbamazepine or lamotrigine, or if your EEG shows unusual patterns that suggest a different type of epilepsy. People with other conditions like progressive myoclonus epilepsy, focal seizures, a global learning disability, or certain physical differences (dysmorphic syndrome) would not be eligible.

It's important to know that you can't refer yourself to this study. Your doctor would typically need to get involved if they think you might be suitable.

Quick self-check

Have you been diagnosed with Juvenile Myoclonic Epilepsy (JME)?
Did your myoclonic jerks start between the ages of 10 and 25?
Are you currently between 10 and 40 years old?
Do your brainwave tests (EEGs) show typical JME patterns?
Do you not have a global learning disability or other specific medical conditions mentioned?

This is a guide only — the research team will confirm whether you can take part.

What does participation involve?

If you decide to take part in this study, it would involve a single visit where a small blood sample is taken. You would also give permission for the research team to collect some information about your JME diagnosis and a copy of your past brainwave test (EEG) results from your medical records. There are no other tests, medications, or ongoing appointments involved as part of the study; it's just a one-off contribution.

Potential risks and benefits

For those who take part, there are no direct health benefits. However, the information you provide could help scientists better understand JME, potentially leading to improved treatments and earlier diagnosis for future patients. The main risk involved is the minor discomfort, and very small chance of bruising, that comes from having blood taken. You are free to choose whether or not to take part, and you can change your mind and withdraw from the study at any time without it affecting your medical care.

Locations (15)

Mount Sinai-Beth Israel Medical Center
New York, United States· Completed
St Luke's Roosevelt Hospital
New York, United States· Completed
Nationwide Children's Hospital
Columbus, United States· Completed
Hospital for Sick Kids
Toronto, Canada· Recruiting
Charles University
Prague, Czechia· Recruiting
Danish National Epilepsy Centre
Dianalund, Denmark· Recruiting
Tallinn Children's Hospital
Tallinn, Estonia· Recruiting
University Robert Debré
Paris, France· Recruiting
Commissione Genetica Lega Italiana contro l'Epilepssia
Roma, Italy· Recruiting
Vestre Viken Health Trust, Oslo
Drammen, Norway· Recruiting
Walton Centre for Neurology and Neurosurgery
Liverpool, United Kingdom· Recruiting
Royal London Hospital
London, United Kingdom· Recruiting

+3 more sites — see the official record for the full list.

Common questions

What is Juvenile Myoclonic Epilepsy (JME)?

JME is a common type of epilepsy that usually starts in teenage years. It often involves sudden, brief muscle jerks, especially after waking up.

Why is this study important for people with JME?

By finding the specific genetic causes of JME, this study aims to pave the way for better treatments and possibly earlier diagnosis in the future.

Do I need to visit a special clinic if I take part?

You would typically have one visit to provide a blood sample. All other information will be collected from your existing medical records.

Will taking part affect my current epilepsy treatment?

No, taking part in this study will not affect your current treatment or medical care in any way.

Is my personal information kept private?

Yes, all your personal and health information collected for the study will be treated confidentially and kept secure.

How to find out more

Deb K Pal, MD PhD

deb.pal@kcl.ac.uk +442078480608 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.